Pulmatrix's stock rockets after deal with Cipla Technologies to develop, commercialize asthma treatment [MarketWatch]
Pulmatrix, Inc. (PULM)
Last pulmatrix, inc. earnings: 8/5 09:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.pulmatrix.com
Company Research
Source: MarketWatch
Pulmatrix's stock rockets after deal with Cipla Technologies to develop, commercialize asthma treatment Shares of Pulmatrix Inc. PULM, +77.95% more than doubled Monday, rocketing 124% on heavy volume, after the company said it entered into a "binding term sheet" with Cipla Ltd. subsidiary Cipla Technologies LLC for the development and commercialization of its asthma treatment Pulmazole. Trading volume spiked to 48.2 million shares, compared with the full-day average of about 834,000 shares. Under terms of the deal, Cipla will make an upfront payment of $22 million in exchange for all rights of Pulmazole, but Pulmatrix will retain the right to receive 50% of the free cash flow from future sales of Pulmazole. Once the deal is closed, Pulmatrix said it believes it will be in a position to complete the phase 2 study, which is planned to begin in the second quarter of 2019. Pulmatrix's stock has still lost 44% over the past 12 months, while the S&P 500 SPX, +1.07% has gained 8.4%. H
Show less
Read more
Impact Snapshot
Event Time:
PULM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PULM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PULM alerts
High impacting Pulmatrix, Inc. news events
Weekly update
A roundup of the hottest topics
PULM
News
- Pulmatrix, Inc. (NASDAQ: PULM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Pulmatrix, Inc. (NASDAQ: PULM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- 14-alpha Demethylase Inhibitors Drug Landscape Research Report 2024: Comprehensive Insights on 12+ Companies and 12+ Pipeline Drugs [Yahoo! Finance]Yahoo! Finance
- Pulmatrix, Inc. (NASDAQ: PULM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Pulmatrix, Inc. (NASDAQ: PULM) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
PULM
Sec Filings
- 3/28/24 - Form 424B3
- 3/28/24 - Form 10-K
- 3/28/24 - Form 8-K
- PULM's page on the SEC website